Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide

Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide

US Patent 8552193 · Granted Oct 8, 2013

Estimated economic value: $45,159,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the synthesis of (+) and (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.12016
Polymorphic forms of a GABAA agonist2012
Phenyl acetic acid derivatives2012
Crystalline forms of MC4R agonist and process for synthesis2012
Polymorphic forms of a GABAA agonist2011
Polymorphic form of montelukast sodium2009
Method of preparing inhibitors phosphodiesterase-42007
Process and intermediates for the preparation of 4-aryl piperidines2006
Method of preparing inhibitors of phosphodiesterase-42005
Sorbitol dehydrogenase inhibitors2005
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors2004
Process for the preparation of non-steroidal glucocorticoid receptor modulators2004